Global Bare Metal Stents Market Size By Type (Co-Cr Stent, Pt-Cr Stent), By Application (For Large Vessel ( 3mm), For Small Vessel (<3mm)), By Region, And Segment Forecasts, 2023 to 2032

lobal Bare Metal Stents Market Report Description

The Global Bare Metal Stents Market was valued at USD 1.1 billion in 2023 and is projected to reach USD 1.5 billion by 2031, growing at a CAGR of 4.0% during the forecast period from 2023 to 2031. The market is driven by the rising incidence of cardiovascular diseases (CVDs), growing geriatric population, and cost-effectiveness of bare metal stents (BMS) compared to drug-eluting stents (DES). Bare metal stents continue to be widely used in regions with constrained healthcare budgets, especially in emergency interventions and patients with high bleeding risk.

Drivers:

1. Rising Prevalence of Cardiovascular Diseases:

Cardiovascular diseases remain the leading cause of death globally, prompting increased use of percutaneous coronary interventions (PCI), which in turn fuels the demand for stents, including BMS.

2. Growing Elderly Population:

The aging global population is more susceptible to conditions like coronary artery disease, creating consistent demand for BMS as part of interventional treatments.

3. Cost-Effectiveness in Emerging Markets:

Bare metal stents are more affordable than drug-eluting alternatives, making them preferable in cost-sensitive regions and for patients lacking access to long-term dual antiplatelet therapy.

Restraints:

1. High Restenosis Rates:

Compared to drug-eluting stents, BMS have a higher risk of restenosis, which may limit their adoption in favor of newer-generation DES.

2. Shift Towards Advanced Stent Technologies:

Technological advancements and better outcomes from drug-eluting and bioresorbable stents have led to a decline in the preference for BMS in developed markets.

Opportunity:

1. Expanding Healthcare Access in Low-Income Regions:

Increased healthcare infrastructure in emerging economies provides growth opportunities for BMS manufacturers where affordability remains a key decision factor.

2. Use in Specific Patient Subsets:

BMS are still preferred in certain cases, such as patients at high bleeding risk, those requiring short-term dual antiplatelet therapy, or undergoing non-cardiac surgery soon after PCI.

Market by System Type Insights:

Based on stent type, coronary bare metal stents dominated the market in 2023. These stents are primarily used in the treatment of coronary artery disease, and their demand persists due to their cost-effectiveness and simplicity of use. Peripheral bare metal stents are also gaining momentum due to the increasing awareness and diagnosis of peripheral arterial disease.

Market by End-use Insights:

Hospitals accounted for the largest market share in 2023 due to the high volume of interventional cardiology procedures conducted in these settings. Ambulatory Surgical Centers (ASCs) are projected to grow rapidly owing to shorter procedure times, reduced hospitalization costs, and increasing investments in minimally invasive cardiac care facilities.

Market by Regional Insights:

North America held the largest share in the global bare metal stents market in 2023, driven by a high burden of cardiovascular diseases and advanced healthcare infrastructure. However, Asia-Pacific is expected to experience the highest growth rate during the forecast period due to growing healthcare expenditure, increasing awareness, and a larger population base suffering from coronary artery conditions.

Competitive Scenario:

Key players in the global bare metal stents market include Boston Scientific Corporation, Medtronic plc, Abbott Laboratories, Biosensors International Group, B. Braun Melsungen AG, Terumo Corporation, Biotronik SE & Co. KG, and Cook Medical. These companies are investing in cost-effective solutions and targeting emerging markets to maintain their competitive edge.

Scope of Work – Global Bare Metal Stents Market

Report Metric Details

Market Size (2023) USD 1.1 Billion

Projected Market Size (2031) USD 1.5 Billion

CAGR (2023–2031) 4.0%

Market Segments By Stent Type (Coronary, Peripheral), End-use

Growth Drivers Rise in CVD cases, cost-efficiency, aging population

Opportunities Emerging markets, use in high-bleeding-risk patients

Key Market Developments:

2023: Abbott Laboratories expanded its cardiovascular product portfolio with a new generation of bare metal stents focused on emerging markets.

2024: Boston Scientific announced a new clinical program assessing outcomes of BMS in elderly patients with limited access to dual antiplatelet therapy.

2025: Terumo Corporation introduced an ultra-thin strut BMS optimized for shorter dual therapy duration, gaining regulatory approval in Southeast Asia.

FAQs:

1) What is the current market size of the Global Bare Metal Stents Market?

The market was valued at USD 1.1 billion in 2023.

2) What is the major growth driver of the Global Bare Metal Stents Market?

The rising prevalence of cardiovascular diseases and the cost-effectiveness of BMS are the major growth drivers.

3) Which is the largest region during the forecast period in the Global Bare Metal Stents Market?

North America currently holds the largest market share.

4) Which segment accounted for the largest market share in the Global Bare Metal Stents Market?

The coronary bare metal stents segment accounted for the largest market share.

5) Who are the key market players in the Global Bare Metal Stents Market?

Key players include Boston Scientific, Abbott Laboratories, Medtronic, Terumo Corporation, and Biotronik SE.

Would you like this description formatted